Why Look at Several Genes Instead of Just One?

Mental health medications usually do not work through just one gene.

They act on complex brain systems involving serotonin, dopamine, norepinephrine, receptors, transporters and other signaling pathways. Because many genes help control these systems, it may be more useful to look at several relevant genes together rather than expecting one gene to predict whether a medication will work.

A simple way to think about it is:

Single-gene approach

1. One gene
2. One small piece of the picture

Multiple (Polygenic) approach

1. Several genes in the same medication pathway
2. A broader view of how that pathway may function

For example, an antidepressant may act mainly on serotonin, but its effect can depend on several parts of the serotonin system, including the serotonin transporter and different serotonin receptors. Looking at only one of these genes may miss the influence of the others.

It is similar to judging how well a car will perform by looking only at the engine. The engine matters, but so do the transmission, brakes, tires and electronics. The whole system works together.

Why This May Be Helpful

A polygenic approach may provide a more complete picture because medication response is usually influenced by:

• Several genes
• Several brain pathways
• Drug metabolism
• Symptoms and diagnosis
• Previous treatment experience Overall medication response

Important limitation

For pharmacokinetic genes, such as CYP2D6 and CYP2C19, there is strong evidence for certain medications and established prescribing guidelines.

For many pharmacodynamic genes—genes involving receptors and transporters—the evidence is still developing. Individual studies may find associations with medication response, but the findings are not always consistent, and most do not yet have established prescribing guidelines.

For this reason, a polygenic pharmacodynamic result is not interpreted as: “This medication will work.” or: “This medication will fail.”

Instead, it may provide additional information about whether the biological pathway targeted by a medication appears more or less favorable, which can then be considered alongside stronger pharmacokinetic evidence, symptoms, medication history and clinical judgment.

Simple Summary

Mental health medication response is usually influenced by many genes, not just one. Looking at several genes within the same biological pathway may provide a broader picture than a single gene alone. However, while this approach is biologically reasonable, the evidence for many pharmacodynamic genes is still developing. Polygenic information should therefore be used as supportive information, not as a stand-alone prediction of whether a medication will work.